Enter your login e-mail to the account
Search
Search parameters
Search results
- Spolupráca praktického lekára a onkológa v liečení onkologického pacienta
MUDr. Miriam Ladická
(3/2006, Consilium ) - Individual approach choosing appropriate therapy for patient with multiple sclerosis
prof. MUDr. Ľubomír Lisý, DrSc.
(5/2016, Interdisciplinary consilium ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(2/2017, Interdisciplinary consilium ) - Is concern about vaccination in patients with multiple sclerosis reasonable?
MUDr. Iveta Lisá, PhD.
(2/2016, Interdisciplinary consilium ) - Possibilities for early detection of patients with the diagnosis of MS in general practitioner
prof. MUDr. Egon Kurča, PhD., MUDr. Natália Jankovičová,
(3/2016, Interdisciplinary consilium ) - Hyperthyroidism from the perspective of clinician
Doc. MUDr. Zdeněk Fryšák, CSc., doc. MUDr. David Karásek, Ph.D., MUDr. Milan Halenka, Ph.D.
(4/2015, Review articles ) - The diagnosis and treatment of multiple sclerosis
doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(4/2015, Interdisciplinary consilium ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - CHRONIC LYMPHOCYTIC LEUKEMIA
prof. MUDr. Elena Tóthová, CSc.
(12/2008, Topic )
- New drugs era in treating multiple sclerosis
MUDr. Marta Vachová
(5/2009, Review articles ) - Safety monitoring of escalation treatment of multiple sclerosis
MUDr. Jiří Piťha
(5/2019, Review articles ) - Alemtuzumab treatment in multiple sclerosis: real clinical experience
MUDr. Viktória Halušková, MUDr. Zbyšek Pavelek, PhD., doc. MUDr. Martin Vališ, Ph.D.
(5/2019, Case reports ) - Autoimmune encephalitides
MUDr. David Krýsl, Ph.D.
(6/2015, Main topic ) - Cognitive impairment in multiple sclerosis
doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(6/2015, Review articles ) - Role of T and B cells in pathogenesis of multiple sclerosis
prof. RNDr. Jan Krejsek, CSc., doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(2/2016, Review articles ) - Hair loss due to treatment of multiple sclerosis
MUDr. Radek Litvik, MUDr. Olga Zapletalová
(2/2017, From the boundary of neurology ) - The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Woman and multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD.
(6/2014, Main topic ) - The individual preferences in choice of suitable MS treatment therapy
MUDr. Marta Vachová
(6/2014, Review articles ) - Recent advances in treatment of multiple sclerosis with interferon beta in Czech Republic?
MUDr. Michal Dufek
(1/2011, Review articles ) - Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - Safety aspects of treating relapsing-remitting multiple sclerosis
MUDr. Radek Ampapa, MUDr. Stanislav Kopecký
(5/2016, Review articles ) - NEDA-4 concept as a treatment outcome in multiple sclerosis patients
MUDr. Pavel Hradílek, Ph.D.
(3/2016, Review articles ) - Clinical experience with alemtuzumab
MUDr. Eva Meluzínová, MUDr. Jana Libertínová, MUDr. Petra Lišková
(3/2016, Case reports ) - Multiple sclerosis and pregnancy
MUDr. Olga Zapletalová
(4/2014, Review articles ) - Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective
Prof. MUDr. Tomáš Kozák, Ph.D.
(6/2016, From the boundary of neurology ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Magnetic resonance imaging for detection of opportunistic infection of patients with multiple sclerosis
doc. MUDr. Dana Horáková, Ph.D., prof. MUDr. Manuela Vaněčková, Ph.D.
(6/2016, Review articles ) - Escalation therapy in multiple sclerosis
MUDr. Pavel Ryška, Ph.D., doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(6/2016, Case reports ) - Treatment of multiple sclerosis in Czech Republic – options and reality
MUDr. Michal Dufek
(1/2014, Review articles ) - Súčasné možnosti dlhodobej liečby roztrúsenej sklerózy: výhody a nevýhody perorálnej liečby roztrúsenej sklerózy
MUDr. Zuzana Matejčíková, Ph.D.
(3/2018, Review articles ) - Listeria meningitis after administration of alemtuzumab for relapsing-remitting multiple sclerosis
MUDr. Pavel Hradílek, Ph.D., MUDr. Petr Hon
(3/2017, Case reports ) - Alemtuzumab in multiple sclerosis treatment
MUDr. Eva Meluzínová
(4/2015, Pharmacotherapy ) - The risk of developing malignant tumors in the modern treatment of multiple sclerosis: a review of the literature
MUDr. Dagmar Brančíková, Ph.D.
(2/2019, From the boundary of neurology ) - Sclerosis multiplex
doc. MUDr. Jarmila Szilasiová, PhD.
(2/2014, Main topic ) - New perspective treatment of multiple sclerosis
doc. MUDr. Vladimír Donáth, CSc., MUDr. Silvia Laurincová
(2/2014, Main topic ) - Multiple sclerosis and its treatment in pregnancy from the viewpoint of the Czech Teratology Information Service: assessment of embryotoxicity risk of pharmacotherapy based on previous experience
MUDr. Lucie Hubičková Heringová, Ph.D., MUDr. Eva Maňáková, Ph.D.
(6/2010, Review articles ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(4/2016, Review articles ) - Treatment with the monoclonal antibody alemtuzumab: effect on the manifestation of thyroid disorders
Prof. MUDr. Petr Vlček, CSc., RNDr. Dana Nováková
(4/2017, From the boundary of neurology ) - New ways of administering injection drugs in relapsing multiple sclerosis
MUDr. Jiří Piťha
(5/2015, Review articles ) - Clinical experiences in multiple sclerosis patients treated with alemtuzumab
MUDr. Mária Ďurišová, MUDr. Eva Recmanová
(2/2020, Case reports ) - Clinically isolated syndrome and treatment with glatiramer acetate
MUDr. Radek Ampapa, MUDr. Vladislav Cunder, MUDr. Martin Svárovský
(2/2015, Case reports ) - Does the development of new drugs for multiple sclerosis change the prognosis of the patient?
prof. MUDr. Eva Havrdová, CSc.
(3/2011, Review articles )
- PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
prof. RNDr. Viliam Foltán, CSc., Mgr. Veronika Dubajová, PharmDr. Tomáš Tesař, PHD, MBA
(1/2008, Review articles ) - Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - THERAPY OF INVASIVE FUNGAL INFECTION IN IMMUNOSUPPRESSED PATIENTS
doc. MUDr. Petr Sedláček, CSc.
(1/2008, Review articles ) - Lymphoma biologic therapy
MUDr. Andrej Vranovský, PhD.
(1/2011, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - Lymfómové fórum 2010
MUDr. Miriam Ladická
(2/2010, Events ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - WALDENSTRÖM‘S MACROGLOBULINEMIA – EPIDEMIOLOGY, ETHIOPATOGENESIS, DIAGNOSTIC AND TREATMENT
prof. MUDr. Elena Tóthová, CSc.
(5/2008, Review articles ) - DIAGNOSIS AND TREATMENT OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
h. doc. MUDr. Ľuboš Drgoňa, CSc.
(5/2008, Review articles ) - Waldenström‘s macroglobulinemia and treatment
MUDr. Radoslav Greksák, PhD.
(1/2019, Review articles ) - HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles ) - Kritériá minimálnej reziduálnej choroby pri chronickej lymfocytovej leukémii
MUDr. Juliana Holasová, MUDr. Alexander Wild, RNDr. Soňa Ölvecká, Mgr. Mariana Jacková
(2/2018, Review articles ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - Febrile neutropenia
MUDr. Ľuboš Drgoňa, CSc.
(1/2012, Review articles ) - Childhood acute lymphoblastic leukemia: from genome to patient
doc. MUDr. Alexandra Kolenová, PhD.
(1/2016, Main topic ) - CHRONIC LYMPHOCYTIC LEUKEMIA – STAGING AND TREATMENT (PART 2)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(6/2008, Review articles ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Antiemetic therapy – what has brought the last decade?
MUDr. Jana Obertová
(6/2010, Review articles ) - Primary cutaneous lymphomas
MUDr. Miriam Ladická
(2/2014, Main topic ) - Current treatment trends for multiple myeloma – subcutaneous administration of proteasome inhibitor
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Janka Baňáková, MUDr. Hilda Šajgalíková, MUDr. Miroslav Šimek, PhD.
(2/2014, Review articles ) - Chronic lymphocytic leukaemia (editorial)
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2014, Oncohematology Review ) - Laborathory diagnosis of CLL: cytology, flow cytometry
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD.
(3/2014, Oncohematology Review ) - Initial treatment of chronic lymphocytic leukaemia
MUDr. Emília Flochová, PhD.
(5/2014, Oncohematology Review ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Treatment of relapse and refractory chronic lymphocytic leukemia
MUDr. Natália Štecová
(5/2014, Oncohematology Review ) - ASCO 2008, SPRÁVA Z MEDZINÁRODNÉHO STRETNUTIA ONKOLÓGOV
MUDr. Marcela Tkáčová
(4/2008, Events ) - Publikujeme v zahraničí
(1/2018, Information & comments ) - Suplement - Stratégia liečby malígnych lymfómov
(1/2018, online attachment )
- THERAPY OF INVASIVE FUNGAL INFECTION IN IMMUNOSUPPRESSED PATIENTS
doc. MUDr. Petr Sedláček, CSc.
(2/2008, Review articles )
- Biological drugs from the perspective of pharmacy
PharmDr. Katarína Bruchatá, PhD., Mgr. Peter Heinz
(4/2014, Pharmaceutical technology ) - New therapy options for multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(4/2013, Current pharmacotherapy )